Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 19Recruiting 10Active not recruiting 5Unknown 2Enrolling by invitation 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 3CNS 3Lymphoid 2Thoracic 1Other hematologic neoplasm 1Gynecologic 1

Conditions

Lymphoma 330Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Lymphoma, Large B-Cell, Diffuse 213Lymphoma, Non-Hodgkin 194Lymphoma, Follicular 168Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 124Hodgkin Disease 111Leukemia 103Recurrence 101Lymphoma, Mantle-Cell 88Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 57Multiple Myeloma 54Lymphoma, Extranodal NK-T-Cell 54Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Neoplasms 39Leukemia, B-Cell 39Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Lymphoma, Large-Cell, Anaplastic 24Hematologic Neoplasms 24Waldenstrom Macroglobulinemia 23Neoplasms, Plasma Cell 23Mycosis Fungoides 23Immunoblastic Lymphadenopathy 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Cognitive Dysfunction × Lymphoid × Clear all
NCT03476070 2021-09-05

Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)

National University of Singapore

Unknown
236 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Neoplasms, Germ Cell and Embryonal, Cognitive Dysfunction

NCT03661034 2021-08-24

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

Cognito Therapeutics, Inc.

Phase NA Unknown
20 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡